Keisuke Kakisaka

43PUBLICATIONS
95CO-AUTHORS
Predictive and prognostic markersAutoimmunityGastroenterology and hepatologyCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|May 12, 2026
Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 2026.

|Oct 09, 2025
Liver Volumetry Enhances Prediction of Acute Pancreatitis in Acute Liver Failure: A Nationwide Registry Study.

Keisuke Kakisaka, Nobuaki Nakayama, Tokio Sasaki

|Aug 23, 2025
Obesity Decreases Liver-Related Death in Patients With Cirrhosis: A Retrospective Propensity Score-Matched Study.

Kei Endo, Keisuke Kakisaka, Tamami Abe

|May 03, 2025
Autoimmune hepatitis following transition from prednisolone to thrombopoietin receptor agonist therapy in immune thrombocytopenic purpura: A clinical precaution.

Kaname Inarimori, Keisuke Kakisaka, Takuya Watanabe

|May 03, 2025
Nationwide survey of patients with acute liver failure and late-onset hepatic failure in Japan seen between 2016 and 2021.

Nobuaki Nakayama, Masamitsu Nakao, Yoshihito Uchida

|Apr 26, 2025
Optimizing Cabozantinib Dosing in Unresectable Hepatocellular Carcinoma of 7-on/7-off Regimen.

Yudai Fujiwara, Hidekatsu Kuroda, Tamami Abe

Pageof 8